NEXTURN&ROLLKOREA Co., Ltd
Price Chart
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 31.47B KRW |
| Revenue | 89.51B KRW |
| Net Income | -2.35B KRW |
| Total Assets | 358.26B KRW |
| Net Assets | 228.74B KRW |
| Employees | 57 |
| Value | |
| P/B | 0.14x |
| P/S | 0.35x |
| EV/EBITDA | 15.00x |
| FCF Yield | -19.08% |
| Profitability | |
| ROE | -1.03% |
| ROA | -0.66% |
| Op. Margin | 7.25% |
| Revenue Growth | 298.29% |
| Financial Health | |
| Debt Ratio | 156.62% |
| Total Debt | 88.12B KRW |
| FCF | -6.01B KRW |
| Cash | 22.33B KRW |
| Current Ratio | 1.65x |
| Net Debt/EBITDA | 10.14x |
| Performance | |
| 1Y Return | -30.22% |
| 1M Return | -6.59% |
| From 52W High | -36.77% |
| 1Y MDD | -36.75% |
| Trading | |
| Volume | 98,437 shares |
| Foreign Own. | 2.03% |
| Per Share | |
| EPS | -489 KRW |
| BPS | 8,969 KRW |
Company Info
Established in 2000 for manufacturing and selling CNC automatic lathes, the company changed its name to Nexturn Bioscience in 2021 and was listed on KOSDAQ in 2006. It supplies CNC automatic lathes to diverse industries including automotive, communication equipment, medical parts, and electronic home appliances, and also operates businesses in heavy equipment components and semiconductor equipment. Through in-house technology development, it expanded market share with unmanned automation processing equipment. The company is pursuing entry into the new medical device business after successfully completing a national project to develop a cardiovascular interventional procedure assistance robot. Nexturn & Rol Korea was established in 2000 and is headquartered in Yongin-si, Gyeonggi-do.